Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer.

Front Mol Biosci · 2023 · PMC10568464 · PMID 37842640

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the effect of the IL-27 monotherapy did not reach statistical significance in these data, a trend in improved bone quality was observed with the IL-27 treatment increasing bone volume and trabecular bone surface area.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.